Risk-specific optimal cancer screening schedules: an application to breast cancer early detection
- PMID: 22162743
- PMCID: PMC3230228
- DOI: 10.1007/s12561-011-9032-7
Risk-specific optimal cancer screening schedules: an application to breast cancer early detection
Abstract
The optimal schedules for breast cancer screening in terms of examination frequency and ages at examination are of practical interest. A decision-theoretic approach is explored to search for optimal cancer screening programs which should achieve maximum survival benefit while balancing the associated cost to the health care system. We propose a class of utility functions that account for costs associated with screening examinations and value of survival benefit under a non-stable disease model. We consider two different optimization criteria: optimize the number of screening examinations with equal screening intervals between exams but without a pre-fixed total cost; and optimize the ages at which screening should be given for a fixed total cost. We show that an optimal solution exists under each of the two frameworks. The proposed methods may consider women at different levels of risk for breast cancer so that the optimal screening strategies will be tailored according to a woman's risk of developing the disease. Results of a numerical study are presented and the proposed models are illustrated with various data inputs. We also use the data inputs from the Health Insurance Plan of New York (HIP) and Canadian National Breast Screening Study (CNBSS) to illustrate the proposed models and to compare the utility values between the optimal schedules and the actual schedules in the HIP and CNBSS trials. Here, the utility is defined as the difference in cure rates between cases found at screening examinations and cases found between screening examinations while accounting for the cost of examinations, under a given screening schedule.
Figures
Similar articles
-
Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.Ont Health Technol Assess Ser. 2007;7(1):1-32. Epub 2007 Jan 1. Ont Health Technol Assess Ser. 2007. PMID: 23074501 Free PMC article.
-
Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.J Natl Cancer Inst. 2005 Aug 17;97(16):1195-203. doi: 10.1093/jnci/dji239. J Natl Cancer Inst. 2005. PMID: 16106024
-
Early detection of disease and scheduling of screening examinations.Stat Methods Med Res. 2004 Dec;13(6):443-56. doi: 10.1191/0962280204sm377ra. Stat Methods Med Res. 2004. PMID: 15587433
-
Digital Breast Tomosynthesis with Hologic 3D Mammography Selenia Dimensions System for Use in Breast Cancer Screening: A Single Technology Assessment [Internet].Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017 Sep 4. Report from the Norwegian Institute of Public Health No. 2017-08. Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017 Sep 4. Report from the Norwegian Institute of Public Health No. 2017-08. PMID: 29553669 Free Books & Documents. Review.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
Cited by
-
Optimal Timing for Cancer Screening and Adaptive Surveillance Using Mathematical Modeling.Cancer Res. 2021 Feb 15;81(4):1123-1134. doi: 10.1158/0008-5472.CAN-20-0335. Epub 2020 Dec 8. Cancer Res. 2021. PMID: 33293425 Free PMC article.
References
-
- American Cancer Society. Detailed guide: breast cancer. Can breast cancer be found early? 2006. [Accessed Dec 2008]. http://www.cancer.org/
-
- American Cancer Society. Breast cancer facts and figures 2009–2010. 2010. [Accessed Aug 2010]. http://www.cancer.org/Research/CancerFactsFigures/BreastCancerFactsFigures/
-
- Boer R, Plevritis S, Clarke L. Diversity of model approaches for breast cancer screening: a review of model assumptions by The Cancer Intervention and Surveillance Network (CISNET) Breast Cancer Groups. Stat Methods Med Res. 2004;13:525–538. - PubMed
-
- Day NE, Walter SD. Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. Biometrics. 1984;40:1–14. - PubMed
-
- Knudsen AB, McMahon PM, Gazelle GS. Use of modeling to evaluate the cost-effectiveness of cancer screening programs. J Clin Oncol. 2007;25:203–208. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources